Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes

Radko Komers, Wei Tian, Jessie N. Lindsley, Terry T. Oyama, David Cohen, Sharon Anderson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

COX-2-derived prostaglandins (PG) have been suggested to be important modulators of renin release and expression. However, the role of COX-2 in various high-renin states is still being debated. In the present studies we explored the role of COX-2-derived PG on basal and angiotensin converting enzyme inhibitor (ACEI)-stimulated plasma and renal renin concentrations (PRC and RRC, RIA), and mRNA expression (RmRNA, RNAse protection assay) in experimental diabetes (DM). Groups of moderately hyperglycemic (n = 5, ∼350 mg/dl), streptozotocin-diabetic rats (D) after 3 weeks of DM were treated with a selective COX-2 inhibitor, MF-tricyclic (MF, 5 mg/kg/day for 10 days in food), the combination of MF and the ACEI enalapril (3 mg/kg/day), enalapril alone, or vehicle (MF-free chow), for 10 days. Non-diabetic control rats, fed MF-free chow, were also studied. All groups of diabetic rats demonstrated similar glycemic control. Treatment with ACEI resulted in significant elevations in PRC, RRC and RmRNA as compared to non-ACEI treated groups of diabetic and control rats. A similar rise in these parameters was observed in the rats treated with the combination of ACEI and MF. Furthermore, in diabetic rats treated with MF alone, PRC and RRC were similar to vehicle-treated animals. Diabetic rats demonstrated higher urinary PG as compared to controls. MF-treated rats demonstrated a significant reduction in urinary PG excretion. In summary, selective COX-2 inhibition influenced neither basal renin status nor ACEI-induced renin release and expression in diabetic rats. These findings do not support a significant role for COX-2 in mediating renin status in diabetes.

Original languageEnglish (US)
Pages (from-to)351-357
Number of pages7
JournalJournal of Laboratory and Clinical Medicine
Volume140
Issue number5
DOIs
StatePublished - Nov 1 2002

Fingerprint

Cyclooxygenase 2
Medical problems
Renin
Rats
Angiotensin-Converting Enzyme Inhibitors
Kidney
Plasmas
Prostaglandins
Rat control
Enalapril
Cyclooxygenase 2 Inhibitors
Enzyme Inhibitors
Streptozocin
Modulators
Assays
Animals
Messenger RNA
Food
Control Groups

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes. / Komers, Radko; Tian, Wei; Lindsley, Jessie N.; Oyama, Terry T.; Cohen, David; Anderson, Sharon.

In: Journal of Laboratory and Clinical Medicine, Vol. 140, No. 5, 01.11.2002, p. 351-357.

Research output: Contribution to journalArticle

Komers, Radko ; Tian, Wei ; Lindsley, Jessie N. ; Oyama, Terry T. ; Cohen, David ; Anderson, Sharon. / Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes. In: Journal of Laboratory and Clinical Medicine. 2002 ; Vol. 140, No. 5. pp. 351-357.
@article{92dad929a7da474cb94f91b8abc9fe44,
title = "Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes",
abstract = "COX-2-derived prostaglandins (PG) have been suggested to be important modulators of renin release and expression. However, the role of COX-2 in various high-renin states is still being debated. In the present studies we explored the role of COX-2-derived PG on basal and angiotensin converting enzyme inhibitor (ACEI)-stimulated plasma and renal renin concentrations (PRC and RRC, RIA), and mRNA expression (RmRNA, RNAse protection assay) in experimental diabetes (DM). Groups of moderately hyperglycemic (n = 5, ∼350 mg/dl), streptozotocin-diabetic rats (D) after 3 weeks of DM were treated with a selective COX-2 inhibitor, MF-tricyclic (MF, 5 mg/kg/day for 10 days in food), the combination of MF and the ACEI enalapril (3 mg/kg/day), enalapril alone, or vehicle (MF-free chow), for 10 days. Non-diabetic control rats, fed MF-free chow, were also studied. All groups of diabetic rats demonstrated similar glycemic control. Treatment with ACEI resulted in significant elevations in PRC, RRC and RmRNA as compared to non-ACEI treated groups of diabetic and control rats. A similar rise in these parameters was observed in the rats treated with the combination of ACEI and MF. Furthermore, in diabetic rats treated with MF alone, PRC and RRC were similar to vehicle-treated animals. Diabetic rats demonstrated higher urinary PG as compared to controls. MF-treated rats demonstrated a significant reduction in urinary PG excretion. In summary, selective COX-2 inhibition influenced neither basal renin status nor ACEI-induced renin release and expression in diabetic rats. These findings do not support a significant role for COX-2 in mediating renin status in diabetes.",
author = "Radko Komers and Wei Tian and Lindsley, {Jessie N.} and Oyama, {Terry T.} and David Cohen and Sharon Anderson",
year = "2002",
month = "11",
day = "1",
doi = "10.1067/mlc.2002.128551",
language = "English (US)",
volume = "140",
pages = "351--357",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes

AU - Komers, Radko

AU - Tian, Wei

AU - Lindsley, Jessie N.

AU - Oyama, Terry T.

AU - Cohen, David

AU - Anderson, Sharon

PY - 2002/11/1

Y1 - 2002/11/1

N2 - COX-2-derived prostaglandins (PG) have been suggested to be important modulators of renin release and expression. However, the role of COX-2 in various high-renin states is still being debated. In the present studies we explored the role of COX-2-derived PG on basal and angiotensin converting enzyme inhibitor (ACEI)-stimulated plasma and renal renin concentrations (PRC and RRC, RIA), and mRNA expression (RmRNA, RNAse protection assay) in experimental diabetes (DM). Groups of moderately hyperglycemic (n = 5, ∼350 mg/dl), streptozotocin-diabetic rats (D) after 3 weeks of DM were treated with a selective COX-2 inhibitor, MF-tricyclic (MF, 5 mg/kg/day for 10 days in food), the combination of MF and the ACEI enalapril (3 mg/kg/day), enalapril alone, or vehicle (MF-free chow), for 10 days. Non-diabetic control rats, fed MF-free chow, were also studied. All groups of diabetic rats demonstrated similar glycemic control. Treatment with ACEI resulted in significant elevations in PRC, RRC and RmRNA as compared to non-ACEI treated groups of diabetic and control rats. A similar rise in these parameters was observed in the rats treated with the combination of ACEI and MF. Furthermore, in diabetic rats treated with MF alone, PRC and RRC were similar to vehicle-treated animals. Diabetic rats demonstrated higher urinary PG as compared to controls. MF-treated rats demonstrated a significant reduction in urinary PG excretion. In summary, selective COX-2 inhibition influenced neither basal renin status nor ACEI-induced renin release and expression in diabetic rats. These findings do not support a significant role for COX-2 in mediating renin status in diabetes.

AB - COX-2-derived prostaglandins (PG) have been suggested to be important modulators of renin release and expression. However, the role of COX-2 in various high-renin states is still being debated. In the present studies we explored the role of COX-2-derived PG on basal and angiotensin converting enzyme inhibitor (ACEI)-stimulated plasma and renal renin concentrations (PRC and RRC, RIA), and mRNA expression (RmRNA, RNAse protection assay) in experimental diabetes (DM). Groups of moderately hyperglycemic (n = 5, ∼350 mg/dl), streptozotocin-diabetic rats (D) after 3 weeks of DM were treated with a selective COX-2 inhibitor, MF-tricyclic (MF, 5 mg/kg/day for 10 days in food), the combination of MF and the ACEI enalapril (3 mg/kg/day), enalapril alone, or vehicle (MF-free chow), for 10 days. Non-diabetic control rats, fed MF-free chow, were also studied. All groups of diabetic rats demonstrated similar glycemic control. Treatment with ACEI resulted in significant elevations in PRC, RRC and RmRNA as compared to non-ACEI treated groups of diabetic and control rats. A similar rise in these parameters was observed in the rats treated with the combination of ACEI and MF. Furthermore, in diabetic rats treated with MF alone, PRC and RRC were similar to vehicle-treated animals. Diabetic rats demonstrated higher urinary PG as compared to controls. MF-treated rats demonstrated a significant reduction in urinary PG excretion. In summary, selective COX-2 inhibition influenced neither basal renin status nor ACEI-induced renin release and expression in diabetic rats. These findings do not support a significant role for COX-2 in mediating renin status in diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0036846124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036846124&partnerID=8YFLogxK

U2 - 10.1067/mlc.2002.128551

DO - 10.1067/mlc.2002.128551

M3 - Article

VL - 140

SP - 351

EP - 357

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 5

ER -